Portfolio (Quarterly)
Guide ↗
Siren, L.L.C.
· CIK 0002005245| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SRRK | Scholar Rock Holding Corp | Healthcare | 9,575,013.0 | $526.6M | 10.66% | NEW | — | $55.00 | -5.4% |
| 2 | KYMR | Kymera Therapeutics Inc | Healthcare | 2,935,830.0 | $336.7M | 6.81% | NEW | — | $114.67 | +5.9% |
| 3 | ERAS | Erasca Inc | Healthcare | 11,397,781.0 | $208.8M | 4.23% | NEW | — | $18.32 | -0.2% |
| 4 | MANE | Veradermics Inc | Healthcare | 1,655,374.0 | $203.5M | 4.12% | NEW | — | $122.94 | -12.0% |
| 5 | TNGX | Tango Therapeutics Inc | Healthcare | 6,179,364.0 | $193.2M | 3.91% | NEW | — | $31.26 | -19.1% |
| 6 | RVMD | Revolution Medicines Inc | Healthcare | 900,000.0 | $168.6M | 3.41% | NEW | — | $187.28 | +13.2% |
| 7 | BCAX | Bicara Therapeutics Inc | Healthcare | 5,602,970.0 | $166.4M | 3.37% | NEW | — | $29.69 | -16.0% |
| 8 | ARWR | Arrowhead Pharmaceuticals Inc | Healthcare | 1,715,476.0 | $139.8M | 2.83% | NEW | — | $81.51 | +8.8% |
| 9 | — | BeOne Medicines AG | — | 465,000.0 | $132.5M | 2.68% | NEW | — | $284.97 | — |
| 10 | EWTX | Edgewise Therapeutics Inc | Healthcare | 3,184,629.0 | $129.4M | 2.62% | NEW | — | $40.63 | +8.4% |
| 11 | RYTM | Rhythm Pharmaceuticals Inc | Healthcare | 1,136,275.0 | $126.2M | 2.55% | NEW | — | $111.03 | +4.0% |
| 12 | LXRX | Lexicon Pharmaceuticals Inc | Healthcare | 44,303,518.0 | $106.3M | 2.15% | NEW | — | $2.40 | -2.5% |
| 13 | ELVN | Enliven Therapeutics Inc | Healthcare | 1,774,411.0 | $90.1M | 1.82% | NEW | — | $50.75 | +17.3% |
| 14 | SYRE | Spyre Therapeutics Inc | Healthcare | 968,598.0 | $86.0M | 1.74% | NEW | — | $88.78 | +17.8% |
| 15 | — | Parabilis Medicines Inc | — | 2,992,259.0 | $81.9M | 1.66% | NEW | — | $27.37 | — |
| 16 | XENE | Xenon Pharmaceuticals Inc | Healthcare | 1,318,564.0 | $79.6M | 1.61% | NEW | — | $60.36 | +3.3% |
| 17 | — | Solid Biosciences Inc | — | 7,690,405.0 | $76.8M | 1.55% | NEW | — | $9.99 | — |
| 18 | ABVX | Abivax SA | Healthcare | 576,000.0 | $76.8M | 1.55% | NEW | — | $133.26 | -9.4% |
| 19 | COAG | Hemab Therapeutics Holdings Inc | — | 2,086,834.0 | $76.6M | 1.55% | NEW | — | $36.73 | +45.9% |
| 20 | RCUS | Arcus Biosciences Inc | Healthcare | 2,420,430.0 | $74.6M | 1.51% | NEW | — | $30.83 | -4.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
92.4%
Technology
3.9%
Communication Services
1.8%
Financial Services
1.3%
Consumer Cyclical
0.6%
Real Estate
0.0%